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Clinics and pathology 
Disease 




One case reported: The patient was a 7-years-old 
female with high white blood count with lymphoblasts 
positive for T-cell antigens; cerebrospinal fluid 
negative for malignant cells; superior mediastinal m ss. 
Prognosis 
The patient attained a complete remission with standard 




The t(14;21)(q11.2;q22) was accompanied with 
del(6)(q21). Cryptic t(14;21) translocation cases may 
exist. 












This gene maps within a 9 to 12 Mb region of 
chromosome 21q22. 
Protein 
This gene was shown to possess a helix-loop-helix 
(bHLH) motif witch inhibits the E2A function in 
transfection assays. E2A is required for normal T-cell 
differentiation. 




Translocation of the BHLHB1 gene 130kb upstream of 
the TCRA enhancer. This translocation activates the 
BHLHB1 gene and produces high levels of BHLHB1 
mRNA. Expression of HLHB1 inhibits E2A-mediated 
transcription activation in vitro. 
Fusion protein 
Note 
No fusion protein. 
Oncogenesis 
Several helix-loop-helix (HLH) proteins are proposed 
to function as transcriptionnal regulatory factors based 
on their ability to bind in vitro the E-box motif of 
transcriptional enhancers.  
The observation that ectopic BHLHB1 expression can 
inhibit E2A activity suggests that BHLHB1 exerts it
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